These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27688105)

  • 1. Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma.
    Taberna M; Resteghini C; Swanson B; Pickard RK; Jiang B; Xiao W; Mena M; Kreinbrink P; Chio E; Gillison ML
    Oral Oncol; 2016 Oct; 61():55-61. PubMed ID: 27688105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.
    Lingen MW; Xiao W; Schmitt A; Jiang B; Pickard R; Kreinbrink P; Perez-Ordonez B; Jordan RC; Gillison ML
    Oral Oncol; 2013 Jan; 49(1):1-8. PubMed ID: 22841678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.
    Wittekindt C; Wuerdemann N; Gattenlöhner S; Brobeil A; Wierzbicka M; Wagner S; Klußmann JP
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3837-3842. PubMed ID: 28861601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation.
    Morshed K; Polz-Dacewicz M; Szymański M; Polz D
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1(Suppl 1):S89-96. PubMed ID: 18193443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
    Lifsics A; Groma V; Cistjakovs M; Skuja S; Deksnis R; Murovska M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
    Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
    Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Prognostic Significance of HPV in Laryngeal Squamous Cell Carcinoma in Northeast China.
    Tong F; Geng J; Yan B; Lou H; Chen X; Duan C; He J; Zhang S; Xie H; Li H; Yuan D; Zhang F; Meng H; Wei L
    Cell Physiol Biochem; 2018; 49(1):206-216. PubMed ID: 30134232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high-risk human papillomavirus types (HPV-16, HPV-18) and their physical status in primary laryngeal squamous cell carcinoma.
    Liu B; Lu Z; Wang P; Basang Z; Rao X
    Neoplasma; 2010; 57(6):594-600. PubMed ID: 20845999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections.
    Lifsics A; Cistjakovs M; Sokolovska L; Deksnis R; Murovska M; Groma V
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma.
    Gheit T; Abedi-Ardekani B; Carreira C; Missad CG; Tommasino M; Torrente MC
    J Med Virol; 2014 Apr; 86(4):642-6. PubMed ID: 24374907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical, radiological and morphological features including the distribution of HPV E6/E7 oncogenes in resection specimens of oropharyngeal squamous cell carcinoma.
    Channir HI; Kiss K; Rubek N; Andersen J; Georgsen JB; Rathje GS; Charabi BW; von Buchwald C; Lajer CB
    Oral Oncol; 2018 Mar; 78():163-170. PubMed ID: 29496046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx.
    Meshman J; Wang PC; Chin R; John MS; Abemayor E; Bhuta S; Chen AM
    Am J Otolaryngol; 2017; 38(1):31-37. PubMed ID: 27751621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas--a tissue microarray study utilizing E6/E7 mRNA in situ hybridization.
    Lewis JS; Ukpo OC; Ma XJ; Flanagan JJ; Luo Y; Thorstad WL; Chernock RD
    Histopathology; 2012 May; 60(6):982-91. PubMed ID: 22360821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of high-risk HPV in benign and malignant lesions of the larynx.
    Duray A; Descamps G; Arafa M; Decaestecker C; Remmelink M; Sirtaine N; Ernoux-Neufcoeur P; Mutijima E; Somja J; Depuydt CE; Delvenne P; Saussez S
    Int J Oncol; 2011 Jul; 39(1):51-9. PubMed ID: 21573490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV16 DNA and integration in normal and malignant epithelium: implications for the etiology of laryngeal squamous cell carcinoma.
    Chen X; Gao L; Sturgis EM; Liang Z; Zhu Y; Xia X; Zhu X; Chen X; Li G; Gao Z
    Ann Oncol; 2017 May; 28(5):1105-1110. PubMed ID: 28327951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.